We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+2.93%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$136M
AUM Growth
+$1.33M
Cap. Flow
-$2.17M
Cap. Flow %
-1.59%
Top 10 Hldgs %
21.77%
Holding
187
New
33
Increased
43
Reduced
61
Closed
33

Sector Composition

Rank Sector Weight
1 Industrials 23.47%
2 Healthcare 19.52%
3 Financials 17.24%
4 Consumer Staples 11.65%
5 Technology 11.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HDS
176
DELISTED
HD Supply Holdings, Inc.
HDS
-16,400
Closed -$502K
PX
177
DELISTED
Praxair Inc
PX
-1,625
Closed -$215K
PRXL
178
DELISTED
Parexel International Corp
PRXL
-24,670
Closed -$2.14M
WFM
179
DELISTED
Whole Foods Market Inc
WFM
-6,600
Closed -$278K
WOOF
180
DELISTED
VCA Inc.
WOOF
-3,200
Closed -$295K

Similar funds

New England Research & Management's Q3 2017 Portfolio in Review

As of Q3 2017, New England Research & Management held 187 positions worth $136M, up 0.98% from $135M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

New England Research & Management's Q3 2017 filing shows 33 new, 43 increased, 61 reduced and 33 closed positions. Its largest new stake was Medtronic: 17,182 shares worth $1.34M. The largest sale was Parexel International Corp, an estimated $2.14M.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • New England Research & Management's largest Q3 2017 buy was Medtronic: 17,182 shares worth $1.34M.
  • New England Research & Management added most to Carnival Corporation Ltd in Q3 2017, an estimated $839K increase.
  • New England Research & Management's biggest Q3 2017 reduction was Amgen, cutting an estimated $1,000K.
  • New England Research & Management fully exited Parexel International Corp in Q3 2017, selling an estimated $2.14M.
  • New England Research & Management's ten largest holdings make up 22% of its $136M portfolio in Q3 2017.
  • New England Research & Management opened 33 new positions and closed 33 in Q3 2017.
  • New England Research & Management's portfolio value rose 0.98% quarter-over-quarter to $136M.

Based on New England Research & Management's 13F filing for Q3 2017, filed 25 Oct 2017.